Home > BIGG > Search result

    Results: 2

    American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support

    Chou, Stella T; Alsawas, Mouaz; Fasano, Ross M; Field, Joshua J; Hendrickson, Jeanne E; Howard, Jo; Kameka, Michelle; Kwiatkowski, Janet L; Pirenne, France; Shi, Patricia A; Stowell, Sean R; Thein, Swee Lay; Westhoff, Connie M; Wong, Trisha E; Akl, Elie A.
    Blood adv. (Online); 4 (2), 2020
    Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease (SCD), but pose significant clinical challenges. Guidance for specific indications and administration of transfusion, as well as screening, prevention, and management of alloimmunization, delayed hemolytic transfusio...
    Anemia, Sickle Cell/prevention & control, Anemia, Sickle Cell/blood, Anemia, Sickle Cell/complications, Blood Transfusion/methods, Hemolytic Plaque Technique/methods
    Fulltext

    Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline

    Compernolle, Veerle; Chou, Stella T; Tanael, Susano; Savage, William; Josephson, Cassandra D; Odame, Isaac; Hogan, Christopher; Denomme, Gregory; Shehata, Nadine.
    Transfus; 58 (6), 2018
    BACKGROUND Red blood cell (RBC) transfusions remain essential in the treatment of patients with sickle cell disease (SCD) and β‐thalassemia. Alloimmunization, a well‐documented complication of transfusion, increases the risk of delayed hemolytic transfusion reactions, complicates crossmatching and i...
    Anemia, Sickle Cell, Erythrocyte Transfusion/22074, Hemoglobinopathies/therapy, Transfusion Reaction/prevention & control, Transfusion Reaction, beta-Thalassemia/therapy, Anemia, Sickle Cell/therapy, Erythrocytes/metabolism, Anemia, Sickle Cell/drug therapy, Erythrocyte Transfusion, Isoantibodies/therapeutic use, Isoantigens/therapeutic use
    Fulltext (primary link)     Fulltext (alternative link)